Open Access. Powered by Scholars. Published by Universities.®
Pharmacy and Pharmaceutical Sciences Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Alternative and Complementary Medicine (1)
- Biochemistry (1)
- Biochemistry, Biophysics, and Structural Biology (1)
- Bioethics and Medical Ethics (1)
- Biophysics (1)
-
- Chemicals and Drugs (1)
- Family Practice Nursing (1)
- Health Information Technology (1)
- Life Sciences (1)
- Lipids (1)
- Nanomedicine (1)
- Nanotechnology (1)
- Natural Products Chemistry and Pharmacognosy (1)
- Nursing (1)
- Occupational and Environmental Health Nursing (1)
- Organic Chemicals (1)
- Other Chemicals and Drugs (1)
- Other Medicine and Health Sciences (1)
- Pharmacy Administration, Policy and Regulation (1)
- Keyword
Articles 1 - 2 of 2
Full-Text Articles in Pharmacy and Pharmaceutical Sciences
Complexation Of Glycoalkaloid Α- Tomatine With Sterols And Its Potential Application As An Anti-Cancer Drug, Bishal Nepal
Complexation Of Glycoalkaloid Α- Tomatine With Sterols And Its Potential Application As An Anti-Cancer Drug, Bishal Nepal
Dissertations
Glycoalkaloids (GAs) are secondary metabolites found mostly in higher plant species and some marine invertebrates. They are known to form complexes with 3β-hydroxy sterols such as cholesterol causing membrane disruption. So far the visual evidence showcasing the complexes formed between glycoalkaloids and sterols has been mainly restricted to some earlier studies using Brewster angle microscopy. This study aimed to develop a method for topographic and morphological analysis of sterol-glycoalkaloid complexes. Langmuir-Blodgett (LB) transfer of monolayers comprising of glycoalkaloid tomatine, sterols, and lipids in varying molar ratios onto mica followed by AFM examination was performed. The AFM method used required minimal …
Evaluating Controlled Substance Documentation In An Electronic Medical Record, Delora Brooks
Evaluating Controlled Substance Documentation In An Electronic Medical Record, Delora Brooks
Dissertations
The Centers for Disease Control and Prevention (CDC) directives issued in 2016 gave guidelines for safely prescribing opiates; however, primary source discussions about methods used for documenting opioid and controlled substance monitoring within an electronic medical record (EMR) are limited (Hussain, Nelson, Polston & Zheng, 2019). This leaves individual providers to determine the appropriate way to document. Inconsistent documentation may not protect providers or organizations from regulatory, civil or criminal liability. As stated by Raveesh, Nayak & Kumbar (2016), “The best way to handle medico-legal issues is by preventing them”. Even with the advent and widespread use of EMRs, documentation …